Table of Content


Introduction
Burns - Overview
Burns - Therapeutics Development
Burns - Therapeutics Assessment
Burns - Companies Involved in Therapeutics Development
Burns - Drug Profiles
Burns - Dormant Projects
Burns - Discontinued Products
Burns - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Burns, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products by Top 10 Targets, H2 2020
Number of Products by Stage and Top 10 Targets, H2 2020
Number of Products by Top 10 Mechanism of Actions, H2 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H2 2020
Number of Products by Routes of Administration, H2 2020
Number of Products by Stage and Routes of Administration, H2 2020
Number of Products by Top 10 Molecule Types, H2 2020
Number of Products by Stage and Top 10 Molecule Types, H2 2020


List of Tables


Number of Products under Development for Burns, H2 2020
Number of Products under Development by Companies, H2 2020
Number of Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Number of Products under Development by Universities/Institutes, H2 2020
Products under Development by Companies, H2 2020
Products under Development by Companies, H2 2020 (Contd..1), H2 2020
Products under Development by Universities/Institutes, H2 2020
Number of Products by Stage and Target, H2 2020
Number of Products by Stage and Mechanism of Action, H2 2020
Number of Products by Stage and Route of Administration, H2 2020
Number of Products by Stage and Molecule Type, H2 2020
Burns - Pipeline by AlgiPharma AS, H2 2020
Burns - Pipeline by Alliance Pharma Plc, H2 2020
Burns - Pipeline by Anterogen Co Ltd, H2 2020
Burns - Pipeline by Bioharmony Therapeutics Inc, H2 2020
Burns - Pipeline by Biomendics LLC, H2 2020
Burns - Dormant Projects, H2 2020
Burns - Dormant Projects, H2 2020 (Contd..1), H2 2020
Burns - Dormant Projects, H2 2020 (Contd..2), H2 2020
Burns - Discontinued Products, H2 2020